Position in NGEN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$64,890
-$31,245 QoQ
Shares Held
31,500
+23.5% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 62 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $9,749,803 across 5 Biotechnology names. NGEN ranks #5 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,049 | $4,494,909 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,458 | $3,148,171 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,005 | $1,873,737 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
19,200 | $168,096 | |
| 5 | NGEN |
Nervgen Pharma Corp.
This page
|
31,500 | $64,890 |
All Filings in NGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,890 | 31,500 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $96,135 | 25,500 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||